JP2008522989A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522989A5
JP2008522989A5 JP2007544750A JP2007544750A JP2008522989A5 JP 2008522989 A5 JP2008522989 A5 JP 2008522989A5 JP 2007544750 A JP2007544750 A JP 2007544750A JP 2007544750 A JP2007544750 A JP 2007544750A JP 2008522989 A5 JP2008522989 A5 JP 2008522989A5
Authority
JP
Japan
Prior art keywords
dosage form
weight
form according
anionic
meth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544750A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008522989A (ja
JP5578764B2 (ja
Filing date
Publication date
Priority claimed from DE102004059792A external-priority patent/DE102004059792A1/de
Application filed filed Critical
Publication of JP2008522989A publication Critical patent/JP2008522989A/ja
Publication of JP2008522989A5 publication Critical patent/JP2008522989A5/ja
Application granted granted Critical
Publication of JP5578764B2 publication Critical patent/JP5578764B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007544750A 2004-12-10 2005-11-05 核酸包含粘膜接着性作用物質を含有する多粒子投与形、および前記投与形を生成する方法 Expired - Fee Related JP5578764B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004059792.8 2004-12-10
DE102004059792A DE102004059792A1 (de) 2004-12-10 2004-12-10 Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
PCT/EP2005/011864 WO2006061069A1 (de) 2004-12-10 2005-11-05 Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte nukleinsäure-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform

Publications (3)

Publication Number Publication Date
JP2008522989A JP2008522989A (ja) 2008-07-03
JP2008522989A5 true JP2008522989A5 (enExample) 2011-09-01
JP5578764B2 JP5578764B2 (ja) 2014-08-27

Family

ID=35709359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544750A Expired - Fee Related JP5578764B2 (ja) 2004-12-10 2005-11-05 核酸包含粘膜接着性作用物質を含有する多粒子投与形、および前記投与形を生成する方法

Country Status (16)

Country Link
US (1) US8568778B2 (enExample)
EP (1) EP1824457B1 (enExample)
JP (1) JP5578764B2 (enExample)
KR (1) KR101319773B1 (enExample)
CN (1) CN101060835B (enExample)
BR (1) BRPI0515815B8 (enExample)
CA (1) CA2586597C (enExample)
DE (1) DE102004059792A1 (enExample)
ES (1) ES2569354T3 (enExample)
HU (1) HUE028793T2 (enExample)
IL (1) IL183753A (enExample)
MX (1) MX2007006343A (enExample)
PL (1) PL1824457T3 (enExample)
SI (1) SI1824457T1 (enExample)
TW (1) TW200635617A (enExample)
WO (1) WO2006061069A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
AU2007265452A1 (en) * 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Active agent formulations, methods of making, and methods of use
EP2164475A2 (en) * 2007-07-16 2010-03-24 NorthEastern University Therapeutic stable nanoparticles
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
EP2521570A4 (en) * 2009-12-29 2015-05-13 Impax Laboratories Inc SOLID ORAL DOSAGE FORMS WITH GASTRORETTENTION EFFECT, COMPRISING AN INFLATABLE HYDROPHILIC POLYMER
MX346316B (es) 2010-02-25 2017-03-15 Evonik Roehm Gmbh Formulacion farmaceutica o nutraceutica.
CN102250878B (zh) * 2011-06-03 2013-01-23 吉林大学 一种基于固相介质表面电荷的反转提取dna的方法
US9107851B2 (en) * 2012-10-15 2015-08-18 New Jersey Institute Of Technology Solventless mixing process for coating pharmaceutical ingredients
JP6912876B2 (ja) * 2016-10-06 2021-08-04 三洋化成工業株式会社 アクリル系医薬固形製剤用添加剤
US11033496B2 (en) * 2017-03-17 2021-06-15 The Regents Of The University Of Michigan Nanoparticles for delivery of chemopreventive agents
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN111989068B (zh) 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
DE102020002360A1 (de) * 2020-04-18 2021-10-21 Friedrich-Schiller-Universität Jena Nanopartikel enthaltend Komplexe aus Nukleinsäuren und kationischen Copolymeren, Verfahren zu deren Herstellung und deren Verwendung zum Gentransfer in Zellen
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
CN117120020A (zh) * 2021-03-30 2023-11-24 塞拉尼斯伊娃高性能聚合物公司 用于递送核酸包封颗粒的植入式医疗器件
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound
EP4545069A4 (en) * 2022-06-24 2026-06-10 Sunsho Pharmaceutical Co Ltd PHARMACEUTICAL COMPOSITION AND ITS PRODUCTION PROCESS
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209174B (enExample) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
DE69634697T2 (de) 1995-10-25 2006-05-04 Octoplus B.V. Kationische polyacrylate und poly(alkyl)acrylate oder die entsprechende acrylamide zur verwendung in synthetischen transfektions-systemen
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6730735B2 (en) 1997-07-03 2004-05-04 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Conjugate of polyethylene glycol and chitosan
AU778049B2 (en) 1999-08-09 2004-11-11 Dainippon Sumitomo Pharma Co., Ltd. Solid preparation containing chitosan powder and process for producing the same
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
WO2003007913A2 (en) * 2001-07-20 2003-01-30 Samir Mitragotri Method for oral drug delivery
US7670627B2 (en) 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
DE10332160A1 (de) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
DE10353186A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
DE102004036437A1 (de) * 2004-07-27 2006-03-23 Röhm GmbH & Co. KG Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE102006035549A1 (de) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht

Similar Documents

Publication Publication Date Title
Yadav et al. Mucoadhesive polymers: means of improving the mucoadhesive properties of drug delivery system
JP5661281B2 (ja) 良好な水溶解性を有する作用物質のための作用物質の制御送達を有する医薬組成物
Roy et al. Polymers in mucoadhesive drug-delivery systems: A brief note
JP4140982B2 (ja) 薬剤形状物用被覆剤及び結合剤及び薬剤形状物
CN101663027B (zh) 包含肠溶包衣的可促进药物释放的固体剂型
KR101454056B1 (ko) 에탄올의 영향에 대하여 내성을 가지는 비-오피오이드용 ｐｈ-의존성 조절 방출 제약 조성물
US4927639A (en) Modified release gemfibrozil composition
CN102006863A (zh) 膜组合物
JP2005514386A5 (enExample)
RU2013111605A (ru) Резистентная к действию желудочного сока фармацевтическая или нутрицевтическая композиция, содержащая одну или более солей альгиновой кислоты
EP0381218B1 (en) Extended release gemfibrozil composition
US7531612B2 (en) pH sensitive polymer and process for preparation thereof
JP2018521030A5 (enExample)
US20060134054A1 (en) Polymer composition for pH dependent dissolution behavior and process for preparation thereof
CN114845700A (zh) Otf的可溶性背衬层
CN101103055B (zh) 经部分中和的阴离子(甲基)丙烯酸酯共聚物
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
JP5534643B2 (ja) 多層剤形
JP2010504318A5 (enExample)
Bromberg Intelligent polyelectrolytes and gels in oral drug delivery
AU2003288706B2 (en) pH sensitive polymer and process for preparation thereof
JP2002536318A5 (enExample)
JP2010506855A5 (enExample)
Devi et al. Polymers for mucoadhesive drug delivery systems.
Vibhooti et al. Eudragit and chitosan—The two most promising polymers for colon drug delivery